27
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Liquorice ( Glycyrrhiza glabra): A phytochemical and pharmacological review

      review-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In the last years, consumers are paying much more attention to natural medicines and principles, mainly due to the general sense that natural compounds are safe. On the other hand, there is a growing demand by industry for plants used in traditional medicine that could be incorporated in foods, nutraceuticals, cosmetics, or even pharmaceuticals. Glycyrrhiza glabra Linn. belongs to the Fabaceae family and has been recognized since ancient times for its ethnopharmacological values. This plant contains different phytocompounds, such as glycyrrhizin, 18β‐glycyrrhetinic acid, glabrin A and B, and isoflavones, that have demonstrated various pharmacological activities. Pharmacological experiments have demonstrated that different extracts and pure compounds from this species exhibit a broad range of biological properties, including antibacterial, anti‐inflammatory, antiviral, antioxidant, and antidiabetic activities. A few toxicological studies have reported some concerns. This review addresses all those issues and focuses on the pharmacological activities reported for G. glabra . Therefore, an updated, critical, and extensive overview on the current knowledge of G. glabra composition and biological activities is provided here in order to explore its therapeutic potential and future challenges to be utilized for the formulation of new products that will contribute to human well‐being.

          Related collections

          Most cited references128

          • Record: found
          • Abstract: found
          • Article: not found

          Review of Pharmacological Effects of Glycyrrhiza sp. and its Bioactive Compounds

          Abstract The roots and rhizomes of licorice (Glycyrrhiza) species have long been used worldwide as a herbal medicine and natural sweetener. Licorice root is a traditional medicine used mainly for the treatment of peptic ulcer, hepatitis C, and pulmonary and skin diseases, although clinical and experimental studies suggest that it has several other useful pharmacological properties such as antiinflammatory, antiviral, antimicrobial, antioxidative, anticancer activities, immunomodulatory, hepatoprotective and cardioprotective effects. A large number of components have been isolated from licorice, including triterpene saponins, flavonoids, isoflavonoids and chalcones, with glycyrrhizic acid normally being considered to be the main biologically active component. This review summarizes the phytochemical, pharmacological and pharmacokinetics data, together with the clinical and adverse effects of licorice and its bioactive components. Copyright © 2008 John Wiley & Sons, Ltd.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Staphylococcus aureus α-Toxin: Nearly a Century of Intrigue

            Staphylococcus aureus secretes a number of host-injurious toxins, among the most prominent of which is the small β-barrel pore-forming toxin α-hemolysin. Initially named based on its properties as a red blood cell lytic toxin, early studies suggested a far greater complexity of α-hemolysin action as nucleated cells also exhibited distinct responses to intoxication. The hemolysin, most aptly referred to as α-toxin based on its broad range of cellular specificity, has long been recognized as an important cause of injury in the context of both skin necrosis and lethal infection. The recent identification of ADAM10 as a cellular receptor for α-toxin has provided keen insight on the biology of toxin action during disease pathogenesis, demonstrating the molecular mechanisms by which the toxin causes tissue barrier disruption at host interfaces lined by epithelial or endothelial cells. This review highlights both the historical studies that laid the groundwork for nearly a century of research on α-toxin and key findings on the structural and functional biology of the toxin, in addition to discussing emerging observations that have significantly expanded our understanding of this toxin in S. aureus disease. The identification of ADAM10 as a proteinaceous receptor for the toxin not only provides a greater appreciation of truths uncovered by many historic studies, but now affords the opportunity to more extensively probe and understand the role of α-toxin in modulation of the complex interaction of S. aureus with its human host.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Tyrosinase inhibitors from natural and synthetic sources: structure, inhibition mechanism and perspective for the future.

              Tyrosinase is known to be a key enzyme in melanin biosynthesis, involved in determining the color of mammalian skin and hair. Various dermatological disorders, such as melasma, age spots and sites of actinic damage, arise from the accumulation of an excessive level of epidermal pigmentation. In addition, unfavorable enzymatic browning of plant-derived foods by tyrosinase causes a decrease in nutritional quality and economic loss of food products. The inadequacy of current conventional techniques to prevent tyrosinase action encourages us to seek new potent tyrosinase inhibitors. This article overviews the various inhibitors obtained from natural and synthetic sources with their industrial importance.
                Bookmark

                Author and article information

                Contributors
                franciscapintolisboa@gmail.com , fsarmento@ff.up.pt
                Journal
                Phytother Res
                Phytother Res
                10.1002/(ISSN)1099-1573
                PTR
                Phytotherapy Research
                John Wiley and Sons Inc. (Hoboken )
                0951-418X
                1099-1573
                17 August 2018
                December 2018
                : 32
                : 12 ( doiID: 10.1002/ptr.v32.12 )
                : 2323-2339
                Affiliations
                [ 1 ] DISTAV University of Genoa Genoa Italy
                [ 2 ] Istituto di Biofisica Consiglio Nazionale delle Ricerche Genoa Italy
                [ 3 ] LAQV/REQUIMTE, Faculty of Pharmacy University of Porto Porto Portugal
                Author notes
                [*] [* ] Correspondence

                Francisca Rodrigues, LAQV/REQUIMTE, Faculty of Pharmacy, University of Porto, Rua Jorge Viterbo Ferreira, 228, 4050‐313 Porto, Portugal.

                Email: franciscapintolisboa@ 123456gmail.com ; fsarmento@ 123456ff.up.pt

                Author information
                http://orcid.org/0000-0001-9154-7789
                http://orcid.org/0000-0001-5280-5490
                http://orcid.org/0000-0001-8803-0041
                http://orcid.org/0000-0002-6767-6596
                Article
                PTR6178 PTR-18-0514.R1
                10.1002/ptr.6178
                7167772
                30117204
                afc6e763-1cf2-49d3-b54c-ea22bff704b1
                © 2018 John Wiley & Sons, Ltd.

                This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

                History
                : 10 April 2018
                : 01 June 2018
                : 20 July 2018
                Page count
                Figures: 0, Tables: 2, Pages: 17, Words: 7555
                Funding
                Funded by: Ministério da Educação e Ciência , open-funder-registry 10.13039/501100003381;
                Funded by: Fundação para a Ciência e a Tecnologia , open-funder-registry 10.13039/501100001871;
                Award ID: Operação NORTE‐01‐0145‐FEDER‐000011
                Funded by: FCT/MEC
                Funded by: European Regional Development Fund , open-funder-registry 10.13039/501100008530;
                Award ID: NORTE‐01‐0145‐FEDER‐000011
                Funded by: Italian Ministry of Education, Universities and Research
                Categories
                Review
                Reviews
                Custom metadata
                2.0
                December 2018
                Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.0 mode:remove_FC converted:15.04.2020

                Pharmacology & Pharmaceutical medicine
                glycyrrhiza glabra,pharmacology,phytochemistry,toxicology,traditional use

                Comments

                Comment on this article